Argitalpenak (28) ELENA LÓPEZ ISAC argitalpenak

2022

  1. Body mass index interacts with a genetic-risk score for depression increasing the risk of the disease in high-susceptibility individuals

    Translational Psychiatry, Vol. 12, Núm. 1

  2. Interaction Effect between Physical Activity and the BDNF Val66Met Polymorphism on Depression in Women from the PISMA-ep Study

    International Journal of Environmental Research and Public Health, Vol. 19, Núm. 4

  3. No evidence that genetic predictors of susceptibility predict changes in core outcomes in JIA

    Rheumatology (United Kingdom), Vol. 61, Núm. 10, pp. 4136-4144

  4. The Effect of Body Fat Distribution on Systemic Sclerosis

    Journal of Clinical Medicine, Vol. 11, Núm. 20

2021

  1. Combined genetic analysis of juvenile idiopathic arthritis clinical subtypes identifies novel risk loci, target genes and key regulatory mechanisms

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 3, pp. 321-328

  2. Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 8, pp. 1040-1047

  3. Expression Quantitative Trait Locus Analysis in Systemic Sclerosis Identifies New Candidate Genes Associated With Multiple Aspects of Disease Pathology

    Arthritis & rheumatology (Hoboken, N.J.), Vol. 73, Núm. 7, pp. 1288-1300

  4. Genomic Risk Score impact on susceptibility to systemic sclerosis

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 1, pp. 118-127

2020

  1. A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

    Scientific Reports, Vol. 10, Núm. 1

  2. Epigenomics and transcriptomics of systemic sclerosis CD4+ T cells reveal long-range dysregulation of key inflammatory pathways mediated by disease-associated susceptibility loci

    Genome Medicine, Vol. 12, Núm. 1

2019

  1. Analysis of the genetic component of systemic sclerosis in Iranian and Turkish populations through a genome-wide association study

    Rheumatology (United Kingdom), Vol. 58, Núm. 2, pp. 289-298

  2. Association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis-related calcinosis

    Rheumatology (United Kingdom)

  3. Correction to: Towards a Better Classification and Novel Therapies Based on the Genetics of Systemic Sclerosis (Current Rheumatology Reports, (2019), 21, 9, (44), 10.1007/s11926-019-0845-6)

    Current Rheumatology Reports

  4. Cross-disorder analysis of schizophrenia and 19 immune-mediated diseases identifies shared genetic risk

    Human Molecular Genetics, Vol. 28, Núm. 20, pp. 3498-3513

  5. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Nature Communications, Vol. 10, Núm. 1

  6. Systemic Sclerosis

    Rare Diseases of the Immune System (Springer Nature), pp. 19-35

  7. Towards a Better Classification and Novel Therapies Based on the Genetics of Systemic Sclerosis

    Current Rheumatology Reports, Vol. 21, Núm. 9

2018

  1. Gene-level association analysis of systemic sclerosis: A comparison of African-Americans and White populations

    PLoS ONE, Vol. 13, Núm. 1

2017

  1. An MIF promoter polymorphism is associated with susceptibility to pulmonary arterial hypertension in diffuse cutaneous systemic sclerosis

    Journal of Rheumatology, Vol. 44, Núm. 10, pp. 1453-1457

  2. Analysis of ATP8B4 F436L Missense Variant in a Large Systemic Sclerosis Cohort

    Arthritis and Rheumatology, Vol. 69, Núm. 6, pp. 1337-1338